PubRank

Mary Collins

Author PubWeight™ 138.39‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 2006 13.74
2 CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002 8.28
3 Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 2011 6.19
4 IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 2008 4.12
5 PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur J Immunol 2002 3.78
6 The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 2001 3.41
7 The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J Clin Invest 2006 3.33
8 IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. Immunity 2002 3.17
9 Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells. J Immunol 2004 3.15
10 Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response. J Exp Med 2003 2.71
11 IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression. J Immunol 2007 2.71
12 Abrogation of Ref1 retrovirus restriction in human cells. J Virol 2002 2.60
13 Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2. J Exp Med 2003 2.54
14 An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. J Immunol 2007 2.46
15 Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells. J Exp Med 2002 2.28
16 Putting evidence into practice: evidence-based interventions for chemotherapy-induced peripheral neuropathy. Clin J Oncol Nurs 2007 2.17
17 Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. Arthritis Rheum 2007 2.10
18 Identification of an interleukin 17F/17A heterodimer in activated human CD4+ T cells. J Biol Chem 2007 2.06
19 KSHV vFLIP binds to IKK-gamma to activate IKK. J Cell Sci 2003 2.04
20 Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses. J Immunol 2003 1.93
21 The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex. J Immunol 2008 1.82
22 Duplication of primate and rodent B7-H3 immunoglobulin V- and C-like domains: divergent history of functional redundancy and exon loss. Genomics 2003 1.81
23 Th17 cytokines and their emerging roles in inflammation and autoimmunity. Immunol Rev 2008 1.75
24 IL-21 induces the apoptosis of resting and activated primary B cells. J Immunol 2003 1.67
25 Continuous high-titer HIV-1 vector production. Nat Biotechnol 2003 1.58
26 Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease. J Clin Invest 2004 1.57
27 IL-21 activates both innate and adaptive immunity to generate potent antitumor responses that require perforin but are independent of IFN-gamma. J Immunol 2003 1.55
28 Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections. J Immunol 2010 1.53
29 PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis. J Neuroimmunol 2006 1.52
30 Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis. J Invest Dermatol 2011 1.51
31 Crystal structure of a vFlip-IKKgamma complex: insights into viral activation of the IKK signalosome. Mol Cell 2008 1.46
32 HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7. J Virol 2010 1.44
33 IL-22 induces an acute-phase response. J Immunol 2010 1.40
34 Use of an objective tool to assess platelet inhibition prior to off-pump coronary surgery to reduce blood usage. J Invasive Cardiol 2012 1.40
35 Nurse case management improves blood pressure, emotional distress and diabetes complication screening. Diabetes Res Clin Pract 2005 1.30
36 PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8+ T cells. EMBO Mol Med 2011 1.27
37 Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen. J Immunol 2005 1.26
38 A phagocytic cell line markedly improves survival of infected neutropenic mice. J Leukoc Biol 2005 1.23
39 IL-21R is essential for epicutaneous sensitization and allergic skin inflammation in humans and mice. J Clin Invest 2008 1.17
40 Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine. J Palliat Med 2005 1.17
41 Optimization of a myeloid cell transfusion strategy for infected neutropenic hosts. J Leukoc Biol 2006 1.11
42 Cloning and functional characterization of the Rhizopus oryzae high affinity iron permease (rFTR1) gene. FEMS Microbiol Lett 2004 1.11
43 Tumor necrosis factor alpha blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells. Arthritis Rheum 2010 1.10
44 Selective ERK activation differentiates mouse and human tolerogenic dendritic cells, expands antigen-specific regulatory T cells, and suppresses experimental inflammatory arthritis. Arthritis Rheum 2011 1.08
45 IL-21 receptor is critical for the development of memory B cell responses. J Immunol 2010 1.05
46 Murine leukemia virus particle assembly quantitated by fluorescence microscopy: role of Gag-Gag interactions and membrane association. J Virol 2003 1.05
47 BTLA: a new inhibitory receptor with a B7-like ligand. Trends Immunol 2003 1.04
48 Inhibition of CTLA-4 function by the regulatory subunit of serine/threonine phosphatase 2A. J Immunol 2002 1.04
49 Selective functional inhibition of JAK-3 is sufficient for efficacy in collagen-induced arthritis in mice. Arthritis Rheum 2010 1.03
50 IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J mice. J Immunol 2012 1.02
51 IL-21 receptor expression determines the temporal phases of experimental autoimmune encephalomyelitis. Exp Neurol 2007 0.98
52 Autoreactive T cells mediate NK cell degeneration in autoimmune disease. J Immunol 2006 0.97
53 IL-22R, IL-10R2, and IL-22BP binding sites are topologically juxtaposed on adjacent and overlapping surfaces of IL-22. J Mol Biol 2008 0.97
54 A strabismus susceptibility locus on chromosome 7p. Proc Natl Acad Sci U S A 2003 0.97
55 DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant. Vaccine 2005 0.97
56 Effect of the internal promoter on insertional gene activation by lentiviral vectors with an intact HIV long terminal repeat. J Virol 2010 0.95
57 B-cell depletion inhibits arthritis in a collagen-induced arthritis (CIA) model, but does not adversely affect humoral responses in a respiratory syncytial virus (RSV) vaccination model. Blood 2005 0.95
58 The β-globin locus control region in combination with the EF1α short promoter allows enhanced lentiviral vector-mediated erythroid gene expression with conserved multilineage activity. Mol Ther 2012 0.93
59 Enhanced GITR/GITRL interactions augment IL-27 expression and induce IL-10-producing Tr-1 like cells. Eur J Immunol 2012 0.92
60 IL-21 effects on human IgE production in response to IL-4 or IL-13. Cell Immunol 2005 0.90
61 Growth factors improve gene expression after lentiviral transduction in human adult and fetal hepatocytes. J Gene Med 2007 0.90
62 Gene transfer to repopulating human CD34+ cells using amphotropic-, GALV-, or RD114-pseudotyped HIV-1-based vectors from stable producer cells. Mol Ther 2005 0.89
63 Therapeutic opportunities in the B7/CD28 family of ligands and receptors. Curr Opin Pharmacol 2005 0.88
64 Insertional mutagenesis by retroviral vectors: current concepts and methods of analysis. Curr Gene Ther 2013 0.87
65 Kaposi's sarcoma-associated herpesvirus vFLIP and human T cell lymphotropic virus type 1 Tax oncogenic proteins activate IkappaB kinase subunit gamma by different mechanisms independent of the physiological cytokine-induced pathways. J Virol 2011 0.86
66 Safer, silencing-resistant lentiviral vectors: optimization of the ubiquitous chromatin-opening element through elimination of aberrant splicing. J Virol 2012 0.86
67 A FLIPR-based assay to assess potency and selectivity of inhibitors of the TEC family kinases Btk and Itk. Assay Drug Dev Technol 2007 0.84
68 Tumor cells secreting IL-13 but not IL-13Ralpha2 fusion protein have reduced tumorigenicity in vivo. Int Immunol 2004 0.83
69 Conjugation of lentivirus to paramagnetic particles via nonviral proteins allows efficient concentration and infection of primary acute myeloid leukemia cells. J Virol 2005 0.82
70 Lentiviral vector expression of tumour antigens in dendritic cells as an immunotherapeutic strategy. Cancer Immunol Immunother 2005 0.82
71 Comparable in vivo efficacy of CD28/B7, ICOS/GL50, and ICOS/GL50B costimulatory pathways in murine tumor models: IFNgamma-dependent enhancement of CTL priming, effector functions, and tumor specific memory CTL. Cell Immunol 2003 0.81
72 Cell-surface and cytokine biomarkers in autoimmune and inflammatory diseases. Drug Discov Today 2006 0.81
73 DNA fusion vaccine designs to induce tumor-lytic CD8+ T-cell attack via the immunodominant cysteine-containing epitope of NY-ESO 1. Int J Cancer 2013 0.81
74 Unexpected targets and triggers of autoimmunity. J Clin Immunol 2014 0.80
75 The pathology and immunology of atopic dermatitis. Inflamm Allergy Drug Targets 2011 0.80
76 Targeting lentiviral vectors for cancer immunotherapy. Curr Cancer Ther Rev 2011 0.80
77 Dehydroepiandrosterone for the treatment of hot flashes: a pilot study. Support Cancer Ther 2006 0.80
78 Pilot evaluation of aprepitant for the treatment of hot flashes. Support Cancer Ther 2006 0.78
79 The DTH effector response and IL-2 are unaffected by cyclosporine A in autoimmune B6D2F1 mice. Cell Immunol 2010 0.78
80 Cytosolic phospholipase A2α blockade abrogates disease during the tissue-damage effector phase of experimental autoimmune encephalomyelitis by its action on APCs. J Immunol 2011 0.77
81 Distinct in vitro binding properties of the anti-CD20 small modular immunopharmaceutical 2LM20-4 result in profound and sustained in vivo potency in cynomolgus monkeys. Rheumatology (Oxford) 2011 0.75
82 Geriatric trauma G-60 falls with hip fractures: A pilot study of acute pain management using femoral nerve fascia iliac blocks. J Trauma Acute Care Surg 2015 0.75